HEATH KOHLMEIER: Open Payments
NPI 1619431566 · FORT BRANCH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 26 payments from 13 companies in 2025. Trend: 2023 $440 · 2024 $433 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Indivior Inc. | 2 | $46 |
| Lundbeck LLC | 1 | $26 |
| Alkermes, Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Corium, LLC | 1 | $17 |
Products named: CAPLYTA, REXULTI, FANAPT, Auvelity, SUBLOCADE, ARISTADA, Jornay PM, HETLIOZ.
Industry payments across IN — which companies pay providers there.
